Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors on Cardiovascular and Metabolic Outcomes in Patients Without Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized‐Controlled Trials

BACKGROUND: Recent studies have increasingly shown that sodium‐glucose cotransporter 2 (SGLT2) inhibitors may have beneficial cardiovascular and metabolic effects in patients without diabetes mellitus. Hence, we conducted a systematic review and meta‐analysis to determine the effect of SGLT2 inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Teo, Yao Hao, Teo, Yao Neng, Syn, Nicholas L., Kow, Cheryl Shumin, Yoong, Celine Shuen Yin, Tan, Benjamin Y. Q., Yeo, Tiong‐Cheng, Lee, Chi‐Hang, Lin, Weiqin, Sia, Ching‐Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Systematic Review and Meta‐analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174267/
https://www.ncbi.nlm.nih.gov/pubmed/33625242
http://dx.doi.org/10.1161/JAHA.120.019463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174267/
https://www.ncbi.nlm.nih.gov/pubmed/33625242
http://dx.doi.org/10.1161/JAHA.120.019463

Ejemplares similares